VIZAMYL
Drug
GE HEALTHCARE
Total Payments
$417,407
Transactions
40
Doctors
16
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $363,040 | 8 | 0 |
| 2021 | $36,805 | 19 | 10 |
| 2020 | $15,162 | 12 | 6 |
| 2017 | $2,400 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $363,040 | 8 | 87.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,805 | 19 | 8.8% |
| Consulting Fee | $17,562 | 13 | 4.2% |
Payments by Type
Research
$363,040
8 transactions
General
$54,367
32 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CT COLLABORATION ON AI TECHNIQUES | GE HEALTHCARE | $160,905 | 0 |
| NEW IDEAS STUDY CLINICAL RESEARCH | GE HEALTHCARE | $133,826 | 0 |
| A DESCRIPTIVE| COMPARATIVE| RANDOMIZED| CROSSOVER STUDY OF FLURPIRIDAZ (18F) INJECTION FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR ASSESSMENT OF MYOCARDIAL PERFUSION IMAGING QUALITY USING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) AND SOLID PHASE EXREACTION (SPE) MANUFACTURING PROCESSES | GE HEALTHCARE | $68,309 | 0 |
Top Doctors Receiving Payments for VIZAMYL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Phoenix, AZ | $363,840 | 9 |
| , MD,PHD | Specialist | Pittsburgh, PA | $8,855 | 2 |
| , MD | Neurology | Philadelphia, PA | $7,200 | 2 |
| , MD | Neurology | Hattiesburg, MS | $6,800 | 4 |
| , MD | Neurology | West Palm Beach, FL | $4,800 | 3 |
| , M.D. PH.D | Nuclear Radiology | Hamden, CT | $3,200 | 2 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Chattanooga, TN | $2,527 | 2 |
| , MD | Interventional Cardiology | Atlanta, GA | $2,527 | 2 |
| , M.D | Nuclear Cardiology | Chattanooga, TN | $2,527 | 2 |
| , MD | Cardiovascular Disease | Salt Lake City, UT | $2,527 | 2 |
| , M.D | Internal Medicine | Tallahassee, FL | $2,527 | 2 |
| , MD | Interventional Cardiology | Kingsport, TN | $2,527 | 2 |
| , M.D | Neurology | Rochester, MN | $2,400 | 2 |
| , MD | Neurology | San Diego, CA | $1,800 | 1 |
| , MD | Neurology | Providence, RI | $1,250 | 1 |
| , M.D | Nephrology | Mill Valley, CA | $1,200 | 1 |
| , MD | Behavioral Neurology & Neuropsychiatry | Silver Spring, MD | $900.00 | 1 |
Ad
Manufacturing Companies
- GE HEALTHCARE $415,007
- GE Healthcare $2,400
Product Information
- Type Drug
- Total Payments $417,407
- Total Doctors 16
- Transactions 40
About VIZAMYL
VIZAMYL is a drug associated with $417,407 in payments to 16 healthcare providers, recorded across 40 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.
Payment data is available from 2017 to 2022. In 2022, $363,040 was paid across 8 transactions to 0 doctors.
The most common payment nature for VIZAMYL is "Unspecified" ($363,040, 87.0% of total).
VIZAMYL is associated with 3 research studies, including "CT COLLABORATION ON AI TECHNIQUES" ($160,905).